Keywords: Eli Lilly, Biotech capabilitie, Multi-specific drugs, Investment

Eli Lilly plans investment to boost its biotech capabilities

Article | 29 June 2011

Print This

US drug major Eli Lilly (NYSE: LLY) yesterday revealed plans for a multi-million dollar investment to expand its existing biotechnology ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in